Atsena Therapeutics is a clinical-stage gene therapy company focused on bringing the life-changing power of genetic medicine to reverse or prevent blindness. They have an ongoing Phase I/II clinical trial evaluating a potential therapy for one of the most common causes of blindness in children. Their additional pipeline of leading preclinical assets is powered by an adeno-associated virus (AAV) technology platform tailored to overcome significant hurdles presented by inherited retinal disease. 

Biotechnology

Atsena Therapeutics

Atsena Therapeutics' headquarters in Durham, NC, United States

Patrick Ritschel

Melissa M Endejann

Kevin Mouillesseaux

Rachel Smith

Sanford Boye

Kenji Fujita

Jennifer Wellman

James Healy

Jackie Grant

Shannon Boye

Mike Dial

Christine Kay

Christina Isacson

Description

People (2)

Jen Franks

Bryan Troxell

Jobs